Fenofibrate Tablet, Coated
Product Images NDC 82009-060

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Fenofibrate (NDC 82009-060). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Quallent Pharmaceuticals Health Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (145 mg (90 Tablet Bottle))

Package Label-principal Display Panel (145 mg (90 Tablet Bottle))
Label for Fenofibrate Tablets USP 145 mg oral tablets, containing 90 tablets per bottle. The label includes dosage form, prescription-only status, and storage instructions. Manufactured by Aurobindo Pharma Limited and labeled for Quallent Pharmaceuticals Health LLC. NDC 82009-060-90 is shown with dosage strength prominently displayed in blue.*
FDA Label Image

Chemical Structure (Fenofibrate Str)

Chemical Structure (Fenofibrate Str)
Chemical structure of Fenofibrate showing its molecular arrangement with chlorophenyl and ester functional groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.